首页> 美国卫生研究院文献>Marine Drugs >Synthesis and in Vitro Antiproliferative Evaluation of Some B-norcholesteryl Benzimidazole and Benzothiazole Derivatives
【2h】

Synthesis and in Vitro Antiproliferative Evaluation of Some B-norcholesteryl Benzimidazole and Benzothiazole Derivatives

机译:一些B-降胆固醇酯类苯并咪唑和苯并噻唑衍生物的合成及体外抗增殖评价

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Taking orostanal (a compound from a Japanese marine sponge, Stelletta hiwasaensis) as a lead compound, some novel B-norcholesteryl benzimidazole and benzothiazole derivatives were synthesized. The antiproliferative activity of the compounds against human cervical carcinoma (HeLa), human lung carcinoma (A549), human liver carcinoma cells (HEPG2) and normal kidney epithelial cells (HEK293T) was assayed. The results revealed that the benzimidazole group was a better substituent than benzothiazole group for increasing the antiproliferative activity of compounds. 2-(3β′-Acetoxy-5β′-hydroxy-6′-B-norcholesteryl)benzimidazole (>9b) with the structure of 6-benzimidazole displays the best antiproliferative activity to the cancer cells in all compounds, but is almost inactive to normal kidney epithelial cells (HEK293T). The assay of compound >9b to cancer cell apoptosis by flow cytometry showed that the compound was able to effectively induce cancer cell apoptosis. The research provided a theoretical reference for the exploration of new anti-cancer agents and may be useful for the design of novel chemotherapeutic drugs.
机译:以Orostanal(一种来自日本海洋海绵,Stelletta hiwasaensis的化合物)为先导化合物,合成了一些新颖的B-降胆固醇酯基苯并咪唑和苯并噻唑衍生物。测定了该化合物对人宫颈癌(HeLa),人肺癌(A549),人肝癌细胞(HEPG2)和正常肾上皮细胞(HEK293T)的抗增殖活性。结果表明,苯并咪唑基团是取代苯并噻唑基团更好的取代基,可提高化合物的抗增殖活性。具有6-苯并咪唑结构的2-(3β'-乙酰氧基-5β'-羟基-6'-B-降胆固醇酯)苯并咪唑(> 9b )在所有化合物中均对癌细胞具有最佳的抗增殖活性,但对正常的肾上皮细胞(HEK293T)几乎没有活性。流式细胞术测定化合物> 9b 对癌细胞的凋亡作用,表明该化合物能够有效诱导癌细胞凋亡。该研究为新型抗癌药物的探索提供了理论参考,可能对新型化疗药物的设计有用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号